Quantcast
Last updated on April 24, 2014 at 21:24 EDT
Existing Cochlear Technology Used To Re-grow Auditory Nerves

Existing Cochlear Technology Used To Re-grow Auditory Nerves

[ Watch The Video: Bionic Ear Delivers DNA To Regrow Auditory Nerve Cells ] University of New South Wales Researchers at UNSW Australia have for the first time used electrical pulses delivered from a cochlear implant to deliver gene...

Latest Professor Stories

2014-04-24 12:54:13

Rates for all other cancers, except female lung cancer, continue to fall Pancreatic cancer is the only cancer for which deaths are predicted to increase in men and women rather than decrease in 2014 and beyond, according to a comprehensive study published in the leading cancer journal Annals of Oncology today (Thursday). The study by researchers in Italy and Switzerland shows that the proportion of deaths due to any sort of cancer is expected to fall overall in Europe in 2014. There are...

2014-04-22 23:09:08

Co-researchers from several Japanese universities found collaboration improvements by visually demonstrating their ideas with the virtual whiteboard meeting app, Share Anytime. Palo Alto, CA (PRWEB) April 22, 2014 Three co-researchers remotely collaborated across Japan using MetaMoJi’s award-winning virtual meeting app, Share Anytime. Each professor reported that the simultaneous editing environment of Share Anytime made it much easier to visualize each other’s inspirations and...

2014-04-15 04:20:50

LONDON, April 15, 2014 /PRNewswire/ -- reViral, an antiviral drug discovery and development company, focused on diseases caused by the respiratory syncytial virus (RSV), today announced the appointment of Professor Raymond Schinazi to its Board as a Non-Executive Director, effective from 9 April 2014. Professor Schinazi has had a long and prestigious career in the industry having founded several successful biotechnology companies including Pharmasset, where he chaired...

2014-04-14 11:03:19

Three new studies presented today at the International Liver CongressTM 2014 have helped clarify the optimal use of combination therapy with peginterferon and nucleoside analogues (NUCs) to achieve the best treatment outcomes in patients with chronic hepatitis B (CHB). "Together these ground-breaking data will go a long way to influencing future CHB treatment guidelines," said EASL's Educational Councillor Professor Cihan Yurdaydin from the Department of Gastroenterology, University of...

2014-04-14 10:54:03

The Lancet Oncology today publishes a major new Commission examining the challenges to effective cancer control in China, India, and Russia – which together experience 46% of all new cancers worldwide, and account for more than half (52%) of all cancer deaths globally. The Commission was led by Professor Paul Goss, of Harvard Medical School and Massachusetts General Hospital Cancer Center, USA, in collaboration with over 40 leading cancer experts from the regions studied, and across the...

2014-04-10 13:46:07

Two new studies presented today at the International Liver CongressTM 2014 have provided more evidence to clarify the role of non-alcoholic fatty liver disease (NAFLD) as an independent risk factor for the development of cardiovascular disease (CVD). In the first long-term study , in patients at high CVD risk, NAFLD was shown to contribute to the progression of early atherosclerosis independently of traditional CVD risk factors. In a second long-term study , NAFLD was confirmed as a...

2014-04-10 11:22:17

Are babies who wake to breastfeed at night trying to delay the birth of a sibling? In a new article published online today in the journal Evolution, Medicine, and Public Health, Professor David Haig argues that infants that wake frequently at night to breastfeed are delaying the resumption of the mother's ovulation and therefore preventing the birth of a sibling with whom they would have to compete. It has already been documented that smaller gaps between the births of siblings are...

2014-04-10 08:30:03

Professor Riccardo Lencioni is giving an honorary lecture on April 24, 2014 which will highlight the latest findings and lessons learned from the HEAT Study and the design of the Phase III OPTIMA Study LAWRENCEVILLE, N.J., April 10, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today that Professor Riccardo Lencioni, MD, FSIR, EBIR, Professor and Director of the Diagnostic Imaging and Intervention at the Pisa University School of Medicine in Italy, former ECIO President,...

2014-04-09 12:32:02

ROME, April 9, 2014 /PRNewswire/ -- Professor Giuseppe Marineo, developer of the patent-protected Scrambler Therapy(R) technology for the treatment of neuropathic and cancer pain, announced today that the Amended, Restated and Extended Service and Representation Agreement between Competitive Technologies, Inc. ("CTI" or "CTTC"), Professor Giuseppe Marineo and Delta Research and Technologies ("Delta"), dated April 1, 2011 and last amended as of June 30, 2012...

2014-04-09 11:43:37

Small financial incentives, totaling as little as £30, can dramatically increase the likelihood of people who inject drugs completing a course of hepatitis B virus (HBV) vaccination, according to new research published in The Lancet. Researchers in the UK found that people undergoing treatment for heroin addiction who received a maximum total of £30 supermarket vouchers in equal or graduated installments in return for full compliance with a regimen of three HBV vaccine injections were at...